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BACKGROUND: The goal of this study was to evaluate the inﬂuence of the duration of postoperative antibiotics (1 day vs. Q 5 days) on wound
infections following surgical treatment of facial fractures.
METHODS: Three hundred thirty-nine patient case histories with a total of 498 fractures were reviewed retrospectively with regard to
infections occurring within a 6-month period following surgical management. Patients were divided into two groups based on
the duration of postoperative antibiotics administered. Group A consisted of 125 patients who had 1 day of postoperative
antibiotics, whereas Group B consisted of 214 patients who had ﬁve or more days of postoperative antibiotics. Statistical
analysis was conducted to assess for possible differences in the rate of postoperative infections.
RESULTS: Five patients in Group A (4%) and seven patients in Group B (3.27%) developed infections within the follow-up period. Of
these 12 patients, seven had sustained multiple facial bone fractures. Eleven infections occurred in patients with mandibular
fractures and one in a midfacial fracture. Statistical analysis using Fisher’s exact test showed no signiﬁcant difference (p = 0.77)
in the incidence of infection between Groups A and B.
CONCLUSION: In this retrospective study, the use of prolonged postoperative antibiotics in uncomplicated mandibular and midfacial fractures
had no signiﬁcant beneﬁt in reducing the incidence of infections. (J Trauma Acute Care Surg. 2014;76: 720Y724. Copyright*
2014 by Lippincott Williams & Wilkins)
LEVEL OF EVIDENCE: Therapeutic study, level IV.
KEY WORDS: Postoperative antibiotics; facial fractures; antimicrobial prophylaxis; trauma.
In maxillofacial trauma, fractures often communicate with theskin surface, oral cavities, or sinus cavities, which are con-
taminated with endogenous ﬂora. Even in closed fractures,
surgical treatment often entails an approach through a contam-
inated ﬁeld. Procedures to surgically reduce and ﬁx these frac-
tures are hence classiﬁed as ‘‘clean-contaminated’’ operations,
with a reported incidence of postoperative infection between
10% and 15% without the use of prophylactic antibiotics.1Y3
The proper use of antibiotics in surgical interventions
for facial fractures can have a signiﬁcant effect on reducing
postoperative infections, as demonstrated by authors such as
Chole and Yee.4 However, the use of prophylactic antibiotics
might have adverse effects and contribute to the development
of resistant strains of bacteria, in addition to the risk of po-
tentially serious adverse reactions in certain individuals. In
the literature, the antibiotic duration varies from a single dose5,6
up to 7 or even 10 days postoperatively.7Y10 The lack of a con-
sensus in the literature as to the most efﬁcacious postoperative
antibiotic regimen after facial fractures led us to conduct a ret-
rospective study in an attempt to answer this question.
In this study, we reviewed the infection rates of our
patients treated before and after April 2011. In April 2011,
following a series of randomized, double-blind, placebo-
controlled studies on the effect of different postoperative anti-
biotic durations on infection conducted in our clinic,11,12 the
standard postoperative antibiotic regimen for facial fractures in
patients with no elevated risk of infection was shortened from
at least 120 hours to 24 hours. This gave us a unique oppor-
tunity to compare the incidence of infections between a 1-day
versus a prolonged (Q5 days) postoperative prophylactic anti-
biotic regimen after surgical intervention in facial fractures.
PATIENTS AND METHODS
Patients
During a period of 3 years fromApril 2009 to April 2012,
583 patients with maxillofacial or mandibular fractures were
surgically treated at theUniversityHospital of Bern,Switzerland,
by surgeons of the Department of Cranio-Maxillofacial Surgery.
At admission, details of each patient such as age, sex,mechanism
of injury, and duration from trauma to admission were routinely
recorded. Preoperative radiographic examination was performed
either with panoramic tomography or computed tomography
scans, depending on the fracture location and surgical re-
quirements. The fracture sites and presence of any other asso-
ciated injuries were noted preoperatively.
These case records were reviewed, and patients were
excluded when any of the following criteria were present: (i)
need for intensive care; (ii) acute bacterial infection, gunshot
wounds, or pathologic fracture (as a result of cysts, metastases,
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etc.); (iii) fracture of the skull base with rhinoliquorrhoea
or intracranial emphysema; (iv) history of malignancy or ra-
diation to the head and neck; (v) compromised host defense
(immunosuppression, malabsorption, maldigestion, cachexia,
bisphosphonate use, agranulocytosis, or reduced body weight
[G40 kg or body mass index G 17); (vi) severe renal insufﬁ-
ciency (stage Q 4 according to the Kidney Disease Outcomes
Quality Initiative);13 (vii) patients with follow-up of less than
6months; or (viii) patients included in other concurrent studies.
Antimicrobial Prophylaxis
All patients were started on intravenous antibiotics on
admission. One of two possible antibiotics was administered.
1. Amoxicillin/clavulanic acid 1.2 g intravenously every
8 hours from admission until 24 hours postoperatively.
2. If the patient was allergic to penicillin, clindamycin 600mg
intravenously every 8 hours from admission until 24 hours
postoperatively was administered instead.
Patients treated from April 2011 to April 2012 (1 year)
whose condition did not require prolonged antibiotic therapy
received no further postoperative antibiotics, just the three doses
of intravenous antibiotics within the ﬁrst 24 hours postopera-
tively (Group A).
Patients treated in the period from April 2009 to
March 2011 (2 years) received postoperatively antibiotics for
5 days or more (Group B). Hence, patients who were on in-
travenous amoxicillin/clavulanic acid then received 1,000 mg
orally three times a day, while patients whowere on intravenous
clindamycin received 300 mg orally three times a day, both for
an additional 4 days or more.
Surgical Technique
All operations were performed under general anesthesia
by a team consisting of a senior surgeon, a junior surgeon, and
a staff member. The surgical site was thoroughly prepared with
a 10% povidone-iodine solution (Betadine, Mundipharma
Medical Company, Basel, Switzerland) or an iodine-free 0.1%
octenidine dihydrochloride (potentiated with addition of 2%
phenoxyethanol) wound disinfection solution (Octenisept,
Schuu¨lke &Mayr, Norderstedt, Germany) if iodine allergy was
reported. Intraoral disinfection was performed with a 0.1%
chlorhexidine gluconate antiseptic solution (Chlorhexamed
0.1%, GlaxoSmithKline, Brentford, United Kingdom). Surgi-
cal approach to the fracture sites was dependent on the loca-
tion and type of fracture and could involve intraoral, extraoral,
transconjunctival, or a combination of these approaches.
Fracture sites included mandibular fractures, fractures
of the zygomatic complex, Le Fort I or II type fractures,
and orbital ﬂoor fractures. Most fractures were reduced and
ﬁxed with titanium miniplates and screws (Medartis, Basel,
Switzerland; or Synthes, Oberdorf, Switzerland; or Stryker,
Solothurn, Switzerland). Where necessary, orbital ﬂoor frac-
tures were reconstructed with an Ethisorb patch (Ethicon Inc.,
NJ), Polymax resorbable plate (Synthes, Oberdorf, Switzerland),
or titanium mesh plate (Medartis or Synthes). The mucosal
incisions were closed using Vicryl or Vicryl-Rapide (Ethicon
Inc.), and skin closure was performed using Prolene sutures
(Ethicon Inc.).
Postoperative Management
Patients were followed up regularly for 6 months after
surgery as per department protocol. All wounds and fracture
sites were inspected at each review appointment to identify any
surgical site infections according to the criteria established by
the Centers for Disease Control and Prevention.14
Criteria for infection included purulent discharge (with
or without microbiologic conﬁrmation), spontaneous wound
dehiscence, abscess formation, or deliberate opening of the
wound by a surgeon in the presence of signs and symptoms of
infection such as localized pain, tenderness, or fever (938-C).
Infection Treatment
In cases of postoperative wound dehiscence or super-
ﬁcial purulent infection, patientswere treatedwith localmeasures
including drainage and daily wound irrigation with povidone-
iodine (Betadine). In cases of deeper infection, the department
protocol included the immediate use of a broad-spectrum an-
tibiotic with subsequent modiﬁcation if needed, depending on
the results of culture and sensitivity tests.
Statistical Analysis
Based on the prevalence of infection after surgical treat-
ment of facial fractures in previous studies, we estimated that a
sample size of 110 in each groupwould be needed for a power of
80% and Type I error level of 5% (one-tailed) (Power and
Precision 3.2, Biostat Inc., NJ). The signiﬁcance of differences
between variables was compared using Fisher’s exact test and
two-sample t test set at a 95% conﬁdence interval (two-tailed)
with the aid of GraphPad Prism (version 5.01 for Windows,
GraphPad Software, San Diego, CA).
RESULTS
Of the 583 patients treated, 244 were excluded from the
study owing to incomplete follow-up (n = 130) or other exclu-
sion criteria (n = 114). Of the remaining 339 patientswho formed
the study population, there were 253 males and 86 females,
with an average age of 42.8 years (range, 16Y90 years) at the
time of trauma and a combined total of 498 fractures between
them. Zygomatic fractures accounted for the largest percent-
age (42.37%), followedbyorbital ﬂoor (33.53%) andmandibular
fractures (23.09%). In comparison, there were only few Le
FortYtype fractures (1.0%). The distribution of fractures and
infections in these patients is summarized in Table 1.
One hundred twenty-ﬁve patients received only 1 day of
postoperative antibiotics, while the other 214 patients received
antibiotics for 5 days or longer (mean [SD], 6.9 [1.9] days). Overall,
12 patients (3.54%) experienced postoperative infectionsVﬁve
patients from Group A (4%) and seven patients from Group B
(3.27%). Only 1 infection occurred in a patient with an isolated
zygomatic complex fracture, while the other 11 infections oc-
curred in mandibular fractures, which involved either the angle
(n = 8) or parasymphysis (n = 3). Of these 11 patients, 7 had
multiple fractures, all of which were within the mandible except
for one, which had an additional zygoma fracture.
The infections manifested as a purulent discharge or
abscess in three patients of each group. The remaining two
J Trauma Acute Care Surg
Volume 76, Number 3 Mottini et al.
* 2014 Lippincott Williams & Wilkins 721
patients in Group A and four patients in Group B experienced
wound dehiscences (Table 2). All patients with infections were
successfully treated with local measures and antibiotics when
necessary as described earlier. No plate removal was necessary.
Statistical analysis showed that Groups A and B were
comparable and that there was no signiﬁcant difference in the
incidence of infection between the groups receiving postop-
erative antibiotics for 1 day versus 5 days or more (p = 0.77).
DISCUSSION
In 1987, Chole and Yee4 showed that the administration
of antibiotics in facial fractures reduced the incidence of in-
fective complications from 42.2% to 8.9%. Since then, the use
of prophylactic antibiotics has become standard practice.
Together with the use of aseptic technique, infection rates after
repair of mandibular fractures have been reduced to 7.3% to
15.2%.3,15Y17 However, the duration of postoperative antibiotic
regimens remains controversial, varying from a single dose5,6
up to even 10 days.18,19 Unfortunately, there are scant data in the
literature comparing infection rates of these various postopera-
tive antibiotic regimens in facial fractures, but in orthognathic
surgery, which is also considered ‘‘clean-contaminated’’surgery,
Bentley et al.20 found a statistically signiﬁcant difference in the
rate of infection between patients who received only 1 day of
postoperative antibiotics (60%) compared with those receiving
5 days of antibiotics (6.7%), which contrasts with the ﬁndings
of others who found no difference.21,22
In our study, prophylactic antibiotics were started on
admission and continued perioperatively, in line with the
TABLE 1. Distribution of Fractures and Infections in the Study Population
Fracture Site
No. Fractures (Percentage of Total) No. Fractures Subdivided by Treatment/Approach/Region
Overall Group A Group B Group A Group B
Orbital ﬂoor fractures 167 (33.53) 65 (13.05) 102 (20.48) Ethisorb patch 51 74
Polymax membrane 14 12
Titanium mesh 0 16
Zygomatic bone fractures 211 (42.37) 72 (14.46) 139 (27.91) Transconjunctival approach 15 36*
Lateral orbital approach 30 72
Intraoral approach 17 12
Percutaneous malar hook 10 19
Mandibular fractures 115 (23.09) 42 (8.43) 73 (14.66) Symphysis 2 5
Parasymphysis 17* 31**
Angle 11**** 17*****
Condyle with plate ﬁxation 2 7
Condyle without plate ﬁxation 10 13
Le Fort I 3 (0.60) 1 (0.20) 2 (0.40)
Le Fort II 2 (0.40) 1 (0.20) 1 (0.20)
Each asterisk indicates a case that developed a surgical site infection.
TABLE 2. Demographic and Clinical Statistics of the Study Population
Group A Group A Infections Group B Group B Infections Total Total Infections
No. patients 125 5 214 7 339 12
Sex
Male 94 5 159 7 253 12
Female 31 0 55 0 86 0
Age at time of trauma, mean (SD), y 43.3 (19.5) 26.6 (9.6) 42.5 (19.4) 31.1 (19.0) 42.8 (19.4) 29.3 (15.3)
Elapsed time between trauma and ﬁrst
administration of antibiotics, mean (SD), d
1.9 (4.0) 2.3 (2.5) 1.6 (4.0) 3.5 (3.9) 1.7 (4.0) 3.0 (3.3)
Duration of preoperative antibiotics, mean (SD), d 1.1 (1.1) 1.6 (1.5) 1.1 (1.4) 0.6 (0.5) 1.1 (1.3) 1.0 (1.1)
Time between trauma and operation, mean (SD), d 2.9 (3.8) 3.8 (2.4) 2.7 (4.0) 4.0 (3.7) 2.8 (3.9) 3.9 (3.1)
Operation duration, mean (SD), min 67.6 (54.4) 160 (55.6) 78.4 (55.4) 128.4 (56.0) 74.4 (55.2) 141.6 (55.7)
Median operation duration, min 45.0 135.0 60.0 134.0 60.0 134.5
Duration of postoperative antibiotics, mean (SD), d 1.0 (0.0) 1.0 (0.0) 6.9 (1.9) 6.7 (1.0) 4.7 (3.2) 4.3 (3.0)
Duration of postoperative stay, mean (SD), d 2.4 (1.4) 2.4 (1.1) 2.4 (1.3) 2.4 (1.0) 2.4 (1.3) 2.4 (1.0)
Duration of entire hospitalization, mean (SD), d 3.5 (2.0) 4.0 (1.6) 3.5 (1.9) 3.0 (1.4) 3.5 (2.0) 3.4 (1.5)
Infections
Abscess/purulent discharge 3 3 6
Wound dehiscence 2 4 6
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experiments performed by Burke,23 who had found that anti-
biotics given four or more hours after injection of bacteria into a
surgical site showed the same degree of cellulitis and inﬂam-
mation as if no antibiotics had been administered. The dura-
tion of postoperative antibiotics depended on whether the study
patient was treated before or after April 2011, when there was
a shift in department protocol toward a shortened postopera-
tive antibiotic regimen in response to emerging evidence from
clinical trials at our department.11,12
The fracture distribution in our study was similar to a
large-scale craniomaxillofacial trauma review performed by
Gassner et al.,24 with midface fractures making up more than
70% of all fractures, mandible fractures approximately 25%,
and a much smaller percentage of Le FortYtype fractures. The
overall rate of infection in our study was 3.54% (of patients)
or 2.41% (of fracture sites), which is much lower than that
reported by Chole and Yee but closer to the study by
Zachariades et al.25 (4.54% of patients, 4.15% of sites). Both
studies however corroborated our ﬁnding of a much higher
incidence of infection after mandibular fractures especially
in the tooth-bearing region, as opposed to a very low rate in
midface fractures. This could then explain our lower overall
infection rate because of the greater proportion of midface
fractures in our study population compared with the majority
mandibular fractures in these two other studies. The number
of patients in our study seemed sufﬁcient for comparison based
on power analysis using the prevalence of infections in facial
fractures of previous studies. However, because of the very
small number of infections in our study, statistical comparison
was limited to the overall numbers and the incidence of in-
fection between Groups A and B, but not between the subset
of patients who experienced infections. We found that there
was no signiﬁcant difference between the groups in the inci-
dence of infection, which indicated that antibiotic prophy-
laxis beyond 24 hours postoperatively did not contribute to the
prevention of postoperative infections. When analyzing po-
tential confounding factors that could have inﬂuenced the
rate of infection between the two groups, we found no statis-
tically signiﬁcant difference with respect to age, interval be-
tween trauma and starting antibiotics or between trauma and
operation, duration of preoperative antibiotics or operation time,
and duration of postoperative stay or entire hospital stay.
In our study population, there was a much higher rep-
resentation of male patients, with a male-to-female ratio of 3:1.
This is consistent with the literature and can be attributed to
more males participating in hazardous activities such as ex-
treme sports or getting involved in altercations and road trafﬁc
accidents especially under the inﬂuence of alcohol. Interest-
ingly, all of the patients who experienced postoperative in-
fections were men. This could be partially caused by the high
proportion of males in the overall study population but could
also be related to poor compliance with postoperative in-
structions and hygiene. This became more apparent when the
etiology of trauma was examined. In the original study popu-
lation, altercations were the cause for just more than a quarter
of the fractures but accounted for 42% in the infected subgroup.
All of these men were in the younger age group and likely to
be noncompliant, and this could also explain why our data
showed a tendency for younger patients to have a higher
incidence of infection. It is also readily apparent from our
results that increased duration of operation led to a higher
incidence of infections, which is well recognized and reported
in the literature.14,26,27
There seemed to be longer mean intervals between
trauma and starting antibiotics or trauma and operation for the
subgroup of patients who experienced infections. This could
be attributed to a couple of outliers who had sought treatment
only after a delay of several days for initially missed fractures,
when symptoms failed to resolve. The outliers however had a
disproportionate inﬂuence on the mean values of these vari-
ables owing to the small number of infections, and hence, these
ﬁgures may not be entirely representative. The timing of the
appearance of postoperative wound infections in our study
was also noteworthy.Wound dehiscence tended to appear much
earlier than abscesses or purulent discharges. Wound dehis-
cence usually became apparent around postoperative Day 10
(mean [SD], 10.7 [5] days), while abscess or purulent discharge
were often detected closer to 4 weeks postoperatively (mean
[SD], 28.5 [19.3] days). This matches our experience in other
clinical situations such as after surgical excision of teeth, where
wound dehiscence would appear earlier while abscesses take
much more time to develop.
There are limitations inherent in all retrospective studies,
and ours is no exception. For example, the inability to stan-
dardize treatment approaches (which varied based on clinical
presentation, intraoperative ﬁndings, and surgeon decision)
and the exact duration of postoperative antibiotics in Group B
have to be highlighted. The duration of preoperative antibi-
otics was also variable, since these operations were consid-
ered ‘‘emergencies’’ and hence could not be scheduled like
elective cases.
Nonetheless, based on the ﬁndings of this retrospec-
tive study, considered in conjunction with the outcome of
previously conducted prospective randomized, double-blind,
placebo-controlled trials in our center,11,12 it can be concluded
that prolonged postoperative prophylactic antibiotic use in facial
fractures does not have a signiﬁcant beneﬁt in reducing the
incidence of infections.
AUTHORSHIP
M.M., O.L., and B.S. contributed in the conception and design of the
study. M.M., R.W., and S.P.L. performed the acquisition of data and
clinical/literature search. M.M., R.W., S.P.L., and B.S. performed the
analysis and interpretation of data collected.M.M., S.P.L., O.L., and B.S.,
drafted the article and/or provided critical revisions. M.M., S.P.L., K.N.,
O.L., and B.S. provided ﬁnal approval and were guarantors of the
manuscript.
DISCLOSURE
The authors declare no conﬂicts of interest.
REFERENCES
1. Flynn NM, Lawrence RM. Antimicrobial prophylaxis. Med Clin North
Am. 1979;63(6):1225Y1244.
2. Peterson LJ. Antibiotic prophylaxis against wound infections in oral and
maxillofacial surgery. J Oral Maxillofac Surg. 1990;48(6):617Y620.
J Trauma Acute Care Surg
Volume 76, Number 3 Mottini et al.
* 2014 Lippincott Williams & Wilkins 723
3. Iizuka T, Lindqvist C, Hallikainen D, Paukku P. Infection after rigid in-
ternal ﬁxation of mandibular fractures: a clinical and radiologic study.
J Oral Maxillofac Surg. 1991;49(6):585Y593.
4. Chole RA, Yee J. Antibiotic prophylaxis for facial fractures. A prospective,
randomized clinical trial. Arch Otolaryngol Head Neck Surg. 1987;
113(10):1055Y1057.
5. Hotz G, Novotny-Lenhard J, Kinzig M, Soergel F. Single-dose antibiotic
prophylaxis in maxillofacial surgery. Chemotherapy. 1994;40(1):65Y69.
6. Merten HA, Halling F. Perioperative antibiotic prophylaxis in maxillofacial
surgery [in German]. Infection. 1993;21(Suppl 1):S45YS48.
7. Zallen RD, Curry JT. A study of antibiotic usage in compound mandibular
fractures. J Oral Surg. 1975;33(6):431Y434.
8. Courtney DJ, Thomas S, Whitﬁeld PH. Isolated orbital blowout fractures:
survey and review. Br J Oral Maxillofac Surg. 2000;38(5):496Y504.
9. Folkestad L, Granstro¨m G. A prospective study of orbital fracture sequelae
after change of surgical routines. J Oral Maxillofac Surg. 2003;61(9):
1038Y1044.
10. Knepil GJ, Loukota RA. Outcomes of prophylactic antibiotics following
surgery for zygomatic bone fractures. J Craniomaxillofac Surg. 2010;
38(2):131Y133.
11. Zix J, Schaller B, Iizuka T, Lieger O. The role of postoperative prophylactic
antibiotics in the treatment of facial fractures: a randomised, double-blind,
placebo-controlled pilot clinical study. Part 1: orbital fractures in 62 patients.
Br J Oral Maxillofac Surg. 2012;52:332Y336.
12. Schaller B, Soong PL, Zix J, Iizuka T, Lieger O. The role of postoperative
prophylactic antibiotics in the treatment of facial fractures: a randomized,
double-blind, placebo-controlled pilot clinical study. Part 2: mandibular
fractures in 59 patients. Br J Oral Maxillofac Surg. 2013;51:803Y807.
13. Bowling CB, Muntner P. Epidemiology of chronic kidney disease among
older adults: a focus on the oldest old. J Gerontol A Biol Sci Med Sci.
2012;67(12):1379Y1386.
14. MangramAJ, Horan TC, PearsonML, Silver LC, JarvisWR. Guideline for
prevention of surgical site infection, 1999. Hospital infection control
practices advisory committee. Infect Control Hosp Epidemiol. 1999;
20(4):250Y278; quiz 279Y280.
15. Lamphier J, Ziccardi V, Ruvo A, Janel M. Complications of mandibular
fractures in an urban teaching center. J Oral Maxillofac Surg. 2003;
61(7):745Y749; discussion 749Y750.
16. Dhariwal DK, Gibbons AJ, Murphy M, Llewelyn J, Gregory MC. A two
year review of the treatment and complications of mandibular angle
fractures. J R Army Med Corps. 2002;148(2):115Y117.
17. Potter J, Ellis E. Treatment of mandibular angle fractures with a malleable
noncompression miniplate. J Oral Maxillofac Surg. 1999;57(3):288Y292;
discussion 292Y293.
18. Heit JM, Stevens MR, Jeffords K. Comparison of ceftriaxone with peni-
cillin for antibiotic prophylaxis for compound mandible fractures. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83(4):423Y426.
19. Bui P, Demian N, Beetar P. Infection rate in mandibular angle fractures
treated with a 2.0-mm 8-hole curved strut plate. J Oral Maxillofac Surg.
2009;67(4):804Y808.
20. Bentley KC, Head TW, Aiello GA. Antibiotic prophylaxis in orthognathic
surgery: a 1-day versus 5-day regimen. J Oral Maxillofac Surg. 1999;
57(3):226Y230; discussion 230Y232.
21. Peterson LJ, Booth DF. Efﬁcacy of antibiotic prophylaxis in intraoral
orthognathic surgery. J Oral Surg. 1976;34(12):1088Y1091.
22. Ruggles JE, Hann JR. Antibiotic prophylaxis in intraoral orthognathic
surgery. J Oral Maxillofac Surg. 1984;42(12):797Y801.
23. Burke JF. The effective period of preventive antibiotic action in experi-
mental incisions and dermal lesions. Surgery. 1961;50:161Y168.
24. Gassner R, Tuli T, Ha¨chl O, Rudisch A, Ulmer H. Cranio-maxillofacial
trauma: a10year reviewof9,543caseswith21,067 injuries.JCraniomaxillofac
Surg. 2003;31(1):51Y61.
25. Zachariades N, Papademetriou I, Rallis G. Complications associated with
rigid internal ﬁxation of facial bone fractures. J Oral Maxillofac Surg.
1993;51(3):275Y278; discussion 278Y279.
26. Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG,
Banerjee SN, Edwards JR, Tolson JS, Henderson TS, et al. Surgical
wound infection rates by wound class, operative procedure, and patient
risk index. National nosocomial infections surveillance system. Am
J Med. 1991;91(3B):152SY157S.
27. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline
for prevention of surgical site infection, 1999. Centers for Disease Control
and Prevention (CDC) Hospital Infection Control Practices Advisory
Committee. Am J Infect Control. 1999;27(2):97Y132; quiz 133Y134;
discussion 196.
J Trauma Acute Care Surg
Volume 76, Number 3Mottini et al.
724 * 2014 Lippincott Williams & Wilkins
